Elena Perpiñán

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis

X. Forns, H. Dahari, F. Graw, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients

F. Zoulim, X. Forns, E. García-Pras, 2020, Journal of hepatology.

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus‐specific CD8+ T cells after direct‐acting antiviral therapies

X. Forns, M. Londoño, G. Koutsoudakis, 2020, Journal of viral hepatitis.

Hepatitis C virus early kinetics and resistance‐associated substitution dynamics during antiviral therapy with direct‐acting antivirals

X. Forns, F. González-Candelas, C. Perales, 2018, Journal of viral hepatitis.

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy

X. Forns, M. Maini, M. Londoño, 2020, Frontiers in Immunology.

Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak

X. Forns, G. Koutsoudakis, Z. Mariño, 2019, Journal of medical virology.

Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January‐June 2017: A hospital perspective

X. Forns, G. Koutsoudakis, Z. Mariño, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.

A. Douiri, J. Hester, F. Issa, 2022, Journal of hepatology.

Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease

R. Lechler, M. Thursz, A. Shah, 2023, EBioMedicine.